BioCentury
ARTICLE | Company News

Management tracks: Arrakis, Astellas

June 28, 2018 12:06 AM UTC

Arrakis Therapeutics Inc. (Waltham, Mass.) founder and CSO Russ Petter is transitioning to Jennifer Petter. The news was announced in a blog post by Chairman and CEO Michael Gilman. "The support for this transition at Arrakis, on the part of the investors, management, and the research team, has been outstanding," Petter told BioCentury. The company discovers and develops RNA-targeted small molecules.

Astellas Pharma Inc. (Tokyo:4503) said Head of Europe, Middle East, and Asia Operations Yukio Matsui will become chief commercial officer. He is succeeded by Dirk Kosche, who was president at the Japanese Novartis Pharma K.K. unit of Novartis AG (NYSE:NVS; SIX:NOVN)...